Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sinclair

Showing results (561-570 of 651) with videos related to

Pageof 66
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1993
Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzne (TCPOBOP) in rat and cultured rat hepatocytesR W Nims, P R Sinclair, J F Sinclair, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2020
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19F A Cadegiani, R K Lim, A Goren, et al.
Toxicology and Applied Pharmacology|May 24, 2005
Arsenite decreases CYP3A23 induction in cultured rat hepatocytes by transcriptional and translational mechanismsTrisha L Noreault, Judith M Jacobs, Ralph C Nichols, et al.
Transplantation Proceedings|December 1, 1982
The effects and side effects of cyclosporine: relationship to drug pharmacokineticsP A Keown, C R Stiller, A L Laupacis, et al.
Toxicology and Applied Pharmacology|April 20, 2004
Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyriaShigeyuki Uno, Timothy P Dalton, Peter R Sinclair, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tardaNadia Gorman, Adrian Zaharia, Heidi S Trask, et al.
Annals of Clinical and Laboratory Science|January 1, 1997
Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3AV E Kostrubsky, J G Szakacs, E H Jeffery, et al.
Chemical Research in Toxicology|March 1, 1993
Pharmacodynamics of cytochrome P450 2B induction by phenobarbital, 5-ethyl-5-phenylhydantoin, and 5-ethyl-5-phenyloxazolidinedione in the male rat liver or in cultured rat hepatocytesR W Nims, P R Sinclair, J F Sinclair, et al.
Toxicology and Applied Pharmacology|April 1, 1997
Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicityV E Kostrubsky, J G Szakacs, E H Jeffery, et al.
The Biochemical Journal|July 1, 1988
Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and in Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compoundsR W Lambrecht, P R Sinclair, W J Bement, et al.
Pageof 66

Showing results (561-570 of 651) with videos related to

Sort By:
Pageof 66
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1993
Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzne (TCPOBOP) in rat and cultured rat hepatocytesR W Nims, P R Sinclair, J F Sinclair, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2020
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19F A Cadegiani, R K Lim, A Goren, et al.
Toxicology and Applied Pharmacology|May 24, 2005
Arsenite decreases CYP3A23 induction in cultured rat hepatocytes by transcriptional and translational mechanismsTrisha L Noreault, Judith M Jacobs, Ralph C Nichols, et al.
Transplantation Proceedings|December 1, 1982
The effects and side effects of cyclosporine: relationship to drug pharmacokineticsP A Keown, C R Stiller, A L Laupacis, et al.
Toxicology and Applied Pharmacology|April 20, 2004
Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyriaShigeyuki Uno, Timothy P Dalton, Peter R Sinclair, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tardaNadia Gorman, Adrian Zaharia, Heidi S Trask, et al.
Annals of Clinical and Laboratory Science|January 1, 1997
Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3AV E Kostrubsky, J G Szakacs, E H Jeffery, et al.
Chemical Research in Toxicology|March 1, 1993
Pharmacodynamics of cytochrome P450 2B induction by phenobarbital, 5-ethyl-5-phenylhydantoin, and 5-ethyl-5-phenyloxazolidinedione in the male rat liver or in cultured rat hepatocytesR W Nims, P R Sinclair, J F Sinclair, et al.
Toxicology and Applied Pharmacology|April 1, 1997
Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicityV E Kostrubsky, J G Szakacs, E H Jeffery, et al.
The Biochemical Journal|July 1, 1988
Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and in Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compoundsR W Lambrecht, P R Sinclair, W J Bement, et al.
Pageof 66